drugset / Trial / NCT02943135

Lidocaine In-situ Gel Before Intrauterine Device Insertion

NCT02943135 ↗

Phase 3 Completed 120 enrolled Assiut University
RandomizedParallel-groupTriple-blindPrevention

Summary

Intrauterine device can cause pain and discomfort in several ways: Use of the tenaculum to grasp the cervix and straighten the uterus for proper insertion; trans-cervical actions including measuring uterine depth, inserting the insertion tube, and removing the tube; and placement of the device in the uterus.

Timeline

Start
2017-10-01
Primary completion
2019-12-31
Completion
2020-03-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lidocaine Other / unclassified — —

Indications

No indication recorded.